Reappraisal of effects of serum chemerin and adiponectin levels and nutritional status on cardiovascular outcomes in prevalent hemodialysis patients

Geriatric nutritional risk index, muscle function, quality of life and clinical outcome in hemodialysis patients

(2016) Ilia Beberashvili et al.   CLINICAL NUTRITION

Chemerin in renal dysfunction and cardiovascular disease

(2016) Mario Bonomini et al.   VASCULAR PHARMACOLOGY

Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients

(2015) Connie M. Rhee et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Independent Association of Circulating Level of Chemerin With Functional and Early Morphological Vascular Changes in Newly Diagnosed Type 2 Diabetic Patients

(2015) Bin Lu et al.   MEDICINE

Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris

(2014) Qingwei Ji et al.   Cardiovascular Diabetology

Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients

(2014) Hung-Yuan Chen et al.   Cardiovascular Diabetology

Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis

(2013) Heng-Hsu Lin et al.   Cardiovascular Diabetology

Low serum fetuin A levels and incident stroke in patients with maintenance haemodialysis

(2013) Hung-Yuan Chen et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease

(2013) S Döcke et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Chemerin gene expression is regulated by food restriction and food restriction–refeeding in rat adipose tissue but not in liver

(2013) Ewa Stelmanska et al.   REGULATORY PEPTIDES

Chemerin as a Mediator between Obesity and Vascular Inflammation in Children

(2012) Kathrin Landgraf et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum Fetuin A and Chemerin Levels Correlate with Hepatic Steatosis and Regional Adiposity in Maintenance Hemodialysis Patients

(2012) Hung-Yuan Chen et al.   PLoS One

Elevated Serum Chemerin Levels are Associated with the Presence of Coronary Artery Disease in Patients with Metabolic Syndrome

(2011) Baokang Dong et al.   INTERNAL MEDICINE

Association of Low Serum Fetuin A Levels With Poor Arteriovenous Access Patency in Patients Undergoing Maintenance Hemodialysis

(2010) Hung-Yuan Chen et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Chemerin Correlates with Markers for Fatty Liver in Morbidly Obese Patients and Strongly Decreases after Weight Loss Induced by Bariatric Surgery

(2010) Henrike Sell et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical importance of an elevated circulating chemerin level in incident dialysis patients

(2010) T. Yamamoto et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Serum Levels of the Adipokine Chemerin in Relation to Renal Function

(2009) D. Pfau et al.   DIABETES CARE

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

(2009) Michael Lehrke et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population

(2009) Kiymet Bozaoglu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Abdominal Obesity and All-Cause and Cardiovascular Mortality in End-Stage Renal Disease

(2009) Maurizio Postorino et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients

(2009) Christiane Drechsler et al.   KIDNEY INTERNATIONAL